A Positron Emission Tomography Occupancy Study Using Ligand [11C]AS2471907 and Following Oral Dosing of ASP3662

Clinical trial NCT02194491 · COMPLETED

Trial details

NCT number: NCT02194491
Sponsor: Astellas Pharma Global Development, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics of ASP3662 Displacement of Radiotracer Healthy Volunteers

Start date: 2014-04-01
Primary completion: 2016-05-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.